These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39268167)

  • 1. FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis.
    Pan H; Luo Z; Lin F; Zhang J; Xiong T; Hong Y; Sun B; Yang Y
    Oncol Lett; 2024 Nov; 28(5):510. PubMed ID: 39268167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer.
    Geng QS; Huang T; Li LF; Shen ZB; Xue WH; Zhao J
    Front Med (Lausanne); 2021; 8():812278. PubMed ID: 35141255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway.
    Chen C; Shen Z
    Protein Pept Lett; 2023; 30(1):54-64. PubMed ID: 36278453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration.
    Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Qian Z; Shen S
    Front Oncol; 2021; 11():756246. PubMed ID: 35141140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis.
    Wan Y; Zhang X; Leng H; Yin W; Zeng W; Zhang C
    PeerJ; 2020; 8():e9120. PubMed ID: 32714651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma.
    Wang J; Wu L; Lu W; Zhang H; Wu Y
    Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844
    [No Abstract]   [Full Text] [Related]  

  • 15. DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy.
    Gao X; Le Y; Geng C; Jiang Z; Zhao G; Zhang P
    Int J Endocrinol; 2022; 2022():5181386. PubMed ID: 36467461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
    Fu X; Zhou X; Ji F; He Q; Qiu X
    Front Genet; 2023; 14():1215984. PubMed ID: 37560385
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
    Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
    BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF10 and IDO1 as a thyroid cancer prognostic biomarker associated with immune infiltration.
    Lv ZB; Zhang JJ; Xiang C
    Heliyon; 2024 Mar; 10(6):e27651. PubMed ID: 38509876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer.
    Xie D; Huang L; Li C; Wu R; Zheng Z; Liu F; Cheng H
    Heliyon; 2024 Jun; 10(11):e31707. PubMed ID: 38845990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.